Boehringer Ingelheim, a leading research-driven biopharmaceutical company, has been lifted to 8th place in the 2024 Access to Medicine Index (ATMI), up from 13th in 2022. This improvement reflects t...
Global system integrator won over by simplicity, security and speed of the Cloudbrink service
SUNNYVALE, Calif., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Cloudbrink has won a major endorsement from Japane...
